FDA Should Scrap Moderate-Risk Review Process: Report
The U.S. Food and Drug Administration's current process for approving moderate-risk medical devices fails to properly evaluate safety and effectiveness, and should be replaced with a new clearance program, the Institute...To view the full article, register now.
Already a subscriber? Click here to view full article